The 12th Edition of the Scientific Days of the National Institute for Infectious Diseases “Prof. Dr. Matei Bals” and the 12th National Infectious Diseases ConferenceHospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania.Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C.Ebola virus disease - a global threatEfficacy and safety of darunavir (Prezista(®)) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, proInsulin resistance and adipokines serum levels in a caucasian cohort of hiv-positive patients undergoing antiretroviral therapy: a cross sectional study.Experimental approach for bacteriophage susceptibility testing of planktonic and sessile bacterial populations - Study protocolThe lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infectionsPrevalence of osteo-renal impairment in the Romanian HIV cohort.Leptin expression in HIV-infected patients during antiretroviral therapy.Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting.Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings.Hepatitis B in the spotlight.Entecavir as specific antiviral therapy in selected cases of severe acute hepatitis BBReast Ecology Assessment in the STudy of local MicroFlora - Study Protocol.Hepatitis C in the interferon-free eraNanoparticles.Colistin in the management of severe infections with multidrug resistant Gram-negative bacilli.An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes.Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.BCG-related granulomatous hepatitis.Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen-positive chronic hepatitis B patients.Microbiologic Safety of the Transareolar Approach in Breast Augmentation.Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patients.Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial.Mathematical functions for modeling the variation of specific medical criteria in some infectious diseases.Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study).Clinical relevance of the plasma load of cytomegalovirus in patients infected with HIV--a survival analysis.Sustained virological response with telaprevir in 1,078 patients with advanced hepatitis C: the international telaprevir access program.Lipodystrophy syndrome in HIV treatment-multiexperienced patients: implication of resistin.Use of quantitative serum HBsAg for optimization of therapy in chronic hepatitis B patients treated with pegylated interferon alfa-2a: a Romanian cohort study.Subphrenic abscess through esophageal leakage after laparoscopic initiated nissen fundoplication--case presentation.Models for the indices of thermal comfort.Response to "Commentary on: Microbiologic Safety of the Transareolar Approach in Breast Augmentation".Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR.Efficacy and safety of peginterferon alpha-2a (40KD) in HBeAg-positive chronic hepatitis B patients.Fahr's syndrome: diagnosis issues in patients with unknown family history of disease.[Current pathogenetic aspects in viral infections of the respiratory system]Possibilities of perfecting antimicrobial therapy. Dynamics of penicillin G concentrations in the cerebro-spinal fluid in purulent meningitis.
P50
Q28553303-D98DF182-7801-4763-8818-27A260E5291DQ33794728-3F34E56F-14EF-4407-97DB-1C5B2646981DQ33834742-7A119DCE-2AD9-4E1D-AC87-586C8620B1D0Q34249226-65787F82-B985-420E-A3A1-857F9B5E48B6Q34249242-E5358947-256E-4381-A904-BE070C15E75FQ34564051-C0C6BE83-A347-4EB1-A7D8-29C33A06773EQ34646257-881C4A34-66C7-4785-B103-20A91051A269Q35201804-CB93F550-2AB9-44B5-8E00-DA89B5A0F34CQ36014923-CCF97F4F-9AC7-4A3A-8062-B2989077318AQ36062324-D61F16EA-C9B4-4ADE-A696-8314EDA632CFQ36722728-84F40FB9-3802-4A11-8EE6-C34500952798Q36844675-0BBA14A0-6E11-47A7-AA32-0108C992A6A0Q37441465-28EDAC47-CDA1-43CD-A7DC-FB0D76B1F934Q37441517-7C4814A9-72F6-44A8-A954-3CEB2788696DQ37441552-D778F8CF-D5B8-460C-877E-BCF7E3414D5BQ37441601-A3CC3FD2-1092-4702-B142-A891AE5122C1Q37441624-64F1FFD2-E421-4CA7-B203-62CC4831BE1FQ37640060-FB1967C3-7A05-477C-8E8A-F0D63278B3E4Q37641267-7E58CBF5-6DA8-4570-BA31-E2293ACF8E99Q38388633-B702A694-ABB7-4D86-8FE5-50CFB52A340AQ40450398-D79D58F1-753D-45DE-BB66-1756ADAE2E1FQ40783580-6FA11798-473B-40C7-8AAA-E9E6ADD8A883Q40901485-2977D1BC-3A3E-4E1E-8312-A5FBAF3BE40FQ40983198-6007646E-CEB2-4F1B-8E38-9CC8BDE6DBC9Q41025039-51DD2624-BDCF-4C5F-9475-E50855D40F73Q41654386-BCC89249-22D7-4362-962F-1981EA3CA759Q41686004-01C187AC-EA4A-445F-A624-AAF2EEF17ECCQ42182803-93B508DB-3B94-4627-B8C9-E77A5D6105C4Q42202214-9056B96C-4106-40E6-8409-46CFA59252F6Q42209774-7FE1AE46-6DA1-485E-9055-88F6DFC1387CQ42228156-EF837C9E-C482-4779-BACB-CBE408C13680Q42268805-F4A1EE41-2474-45AA-A399-34D8C6D6C233Q42643540-E30A269D-70A7-4B9C-BF27-EC9813F0722CQ42643590-30A5DC85-E766-4D14-8FA3-5A99BA00982CQ42675031-2C5B803B-4EF5-43DA-A2E8-8EA2A6D02673Q42965280-6207D0A1-EABD-4F12-96A6-2A09F9DE606DQ43193828-BB4D9EE6-7863-40A4-871C-B4EF889776FCQ43289897-AC696B37-2016-4AD2-AA43-4058B3D21A36Q43642761-8D119380-1FC3-47BF-B31B-F28C0B1E5269Q43956420-9F7DEBBE-16F1-4595-B68B-3F4CF7F30504
P50
description
hulumtues
@sq
medic şi cercetător român
@ro
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Adrian Streinu-Cercel
@ast
Adrian Streinu-Cercel
@en
Adrian Streinu-Cercel
@es
Adrian Streinu-Cercel
@nl
Adrian Streinu-Cercel
@ro
Adrian Streinu-Cercel
@sl
type
label
Adrian Streinu-Cercel
@ast
Adrian Streinu-Cercel
@en
Adrian Streinu-Cercel
@es
Adrian Streinu-Cercel
@nl
Adrian Streinu-Cercel
@ro
Adrian Streinu-Cercel
@sl
prefLabel
Adrian Streinu-Cercel
@ast
Adrian Streinu-Cercel
@en
Adrian Streinu-Cercel
@es
Adrian Streinu-Cercel
@nl
Adrian Streinu-Cercel
@ro
Adrian Streinu-Cercel
@sl
P1053
M-5835-2017
P106
P1153
6603337667
P19
P21
P27
P31
P3829
P496
0000-0001-6382-5067
P569
1956-08-30T00:00:00Z